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Abstract
[C10H17N5O], monoclinic, P21/c (no. 14), a= 8.12150(10) Å,
b= 13.2833(2) Å, c= 11.0258(2) Å, β= 110.083(2)°,
V = 1117.14(3) Å3, Z= 4, Rgt(F)=0.0311, wRref(F2)=0.0790,
T= 100(2) K.
CCDC no.: 1897358
The crystal structure is shown in the figure. Tables 1 and 2
contain details on crystal structure and measurement condi-
tions and a list of the atoms including atomic coordinates and
displacement parameters.
Source of material
The compound was prepared using a microwave-assisted
nucleophilic ring opening of N-guanidinosuccinimide with
piperidine followed by an in situ intramolecular cyclization of
the triazole ring as described in the literature [5]. The crystals
were obtained from the slow evaporation of an acetonitrile
solution of the compound,M. pt: 438–440 K.
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Table 1: Data collection and handling.
Crystal: Prism, colourless
Size: 0.13×0.10×0.04 mm
Wavelength: Cu Kα radiation (1.54178 Å)
µ: 0.74 mm−1
Diffractometer, scan mode: XtaLAB Synergy, ω-scans
θmax, completeness: 67°,>99%
N(hkl)measured, N(hkl)unique, Rint: 13479, 1993, 0.030
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 1851
N(param)refined: 154
Programs: CrysAlisPRO [1], SHELX [2, 3],
WinGX and ORTEP [4]
Experimental details
The C-bound H atoms were geometrically placed (C—
H=0.99 Å) and refinedas ridingwithU iso(H)= 1.2Ueq(C). The
N-boundH-atomswere located in difference Fouriermaps but
were refinedwith adistance restraint ofN—H=0.88±0.01 Å,
and with U iso(H) set to 1.2Uequiv(N).
Discussion
Interest in molecules related to the title compound stem from
the significant biological activity exhibited by 1,2,4-triazoles
[6, 7]. This interest prompts investigations into efficient
synthesis of these derivatives and in this context, recently
two new complementary pathways for the synthesis of
N-substituted 3-(5-amino-1H-1,2,4-triazol-3-yl) propanamides
based on microwave technology were described [5]. The title
compound was one of the species prepared in that study and
herein its crystal and molecular structures are described.
The molecular structure of the title structure is shown in
the Figure (70% displacement ellipsoids) and comprises a 5-
amino-1H-1,2,4-triazol-3-yl residue connected to a piperidinyl
ring via a propan-1-one linker. Tautomerism is possible in the
5-amino-1H-1,2,4-triazol-3-yl ring and crystallography proves
the location of ring-bound hydrogen to be on the N1 atom.
The confirmation for this assignment, besides the pattern of
intermolecular hydrogen bonding (see below), is seen in the
magnitude of the key bond lengths in the ring, i.e. the short-
ening of the C1—N3 [1.3353(14) Å] and C2—N2 [1.3153(15) Å]
bond lengths compared to N1—C1 [1.3435(15) Å], C1—N4
[1.3580(14) Å] and C2—N3 [1.3656(14) Å]. The five-membered
ring is strictly planar [r.m.s. deviation=0.004 Å] with the N4
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Table 2: Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å2).
Atom x y z Uiso*/Ueq
O1 0.21014(10) 0.60094(6) 0.45554(7) 0.0179(2)
N1 0.62336(12) 0.27045(7) 0.91082(9) 0.0147(2)
H1N 0.6756(16) 0.2165(8) 0.9524(12) 0.018*
N2 0.57262(12) 0.27705(7) 0.77780(9) 0.0157(2)
N3 0.49787(12) 0.41829(7) 0.86125(8) 0.0135(2)
N4 0.61209(13) 0.37411(7) 1.08519(9) 0.0164(2)
H2N 0.6160(18) 0.3227(8) 1.1365(12) 0.020*
H3N 0.5707(17) 0.4315(8) 1.1007(13) 0.020*
N5 0.11049(12) 0.45317(7) 0.35760(9) 0.0142(2)
C1 0.57659(13) 0.35488(8) 0.95776(10) 0.0128(2)
C2 0.49991(14) 0.36675(8) 0.75461(10) 0.0135(2)
C3 0.42559(14) 0.40929(9) 0.62122(10) 0.0157(2)
H3A 0.413456 0.354662 0.557645 0.019*
H3B 0.508076 0.459791 0.608852 0.019*
C4 0.24561(14) 0.45915(9) 0.59558(10) 0.0152(2)
H4A 0.159212 0.407622 0.598950 0.018*
H4B 0.254443 0.509921 0.663260 0.018*
C5 0.18422(13) 0.50948(8) 0.46381(10) 0.0132(2)
C6 0.05744(15) 0.34728(9) 0.35458(11) 0.0179(3)
H6A −0.071125 0.341904 0.311597 0.021*
H6B 0.087296 0.321989 0.444031 0.021*
C7 0.14889(16) 0.28295(9) 0.28251(12) 0.0231(3)
H7A 0.103873 0.213138 0.275512 0.028*
H7B 0.276328 0.281231 0.331630 0.028*
C8 0.11793(16) 0.32484(10) 0.14781(12) 0.0245(3)
H8A 0.188701 0.286451 0.106324 0.029*
H8B −0.007211 0.317015 0.094293 0.029*
C9 0.16810(16) 0.43552(10) 0.15500(11) 0.0217(3)
H9A 0.138114 0.462672 0.066412 0.026*
H9B 0.296363 0.442173 0.198611 0.026*
C10 0.07395(15) 0.49690(9) 0.22836(10) 0.0182(3)
H10A 0.114983 0.567582 0.236307 0.022*
H10B −0.053895 0.496396 0.180548 0.022*
[0.046(1) Å] and C3 [0.016(1) Å] atoms lying out of but to the
same side of the plane. Overall, the molecule has the shape
of the letter U as the aliphatic residues lie to the same side of
the bridging region as seen in the values of the C3—C4—C5—
O1 [−96.38(12)°] and C5—N5—C6—C7 [−122.45(11)°] torsion
angles. The piperidinyl ring adopts a chair conformation.
The observed tautomer is as expected based on literature
precedents [8]. However, a compound was recently identified
crystallizingwith a hydrogen located at the nitrogen atom fur-
thest away from the amino group, that is, existing in the form
of the 3-amino-1H-tautomer [9]. It is also noted that an exam-
ple of a crystal comprising both 5-amino-1H- and 3-amino-
1H-tautomers, co-existing in equal proportions, has also been
reported [10].
In the molecular packing, the ring-N1—H1n atom
forms a hydrogen bond to the O1(carbonyl) atom to form
a helical supramolecular chain along the b-axis [N1—
H1n· · ·O1i: H1n· · ·O1i = 1.898(11) Å, N1· · ·O1i = 2.7751(12) Å
with angle at H1n= 179.2(14)° for symmetry operation i:
1− x, −1/2+ y, 3/2− z]. Each of the secondary amine-N4—
H atoms forms a hydrogen bond to a triazolyl-nitrogen
atom [N4—H2n· · ·N2ii: H2n· · ·N2ii = 2.164(12) Å, N4· · ·N2ii
3.0186(13) Å with angle at H1n= 163.5(13)°; N4—H3n· · ·N3iii:
H3n· · ·N3iii = 2.151(11) Å, N4· · ·N3iii = 3.0188(13) Å with
angle at H1n= 172.1(13)° for symmetry operations ii: x, 1/2− y,
1/2+ z and iii: 1− x, 1− y, 2− z]. These hydrogen bonds link
the chains into a supramolecular layer parallel to [1 0 0].
Layers stack along the a axis without directional interactions
between them.
The most closely related structure in the literature is that
of the derivative with an aniline residue connected to the
carbonyl-C5 atom [5]. This molecule adopts the same tau-
tomeric form as reported herein.
Acknowledgements: This work is supported by theMinistry
of Higher Education, Malaysia under Fundamental Research
Grant Scheme (Grant No. FRGS/1/2015/SG01/MUSM/03/1).
References
1. Agilent Technologies. CrysAlis PRO. Agilent Technologies,
Santa Clara, CA, USA (2017).
2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr.
A64 (2008) 112–122.
3. Sheldrick, G. M.: Crystal structure refinement with SHELXL.
Acta Crystallogr. C71 (2015) 3–8.
4. Farrugia, L. J.: WinGX and ORTEP for Windows: an update. J.
Appl. Cryst. 45 (2012) 849–854.
5. Lim, F. P. L.; Tan, L. Y.; Tiekink, E. R. T.; Dolzhenko, A. V.: Synthe-
sis of 3-(5-amino-1H-1,2,4-triazol-3-yl)propanamides and their
tautomerism. RSC Adv. 8 (2018). 22351–22360.
6. Kun, S.; Begum, J.; Kyriakis, E.; Stamati, E. C. V.; Barkas, T.
A.; Szennyes, E.; Bokor, E.; Szabó, K. E.; Stravodimos, G. A.;
Sipos, A.; Docsa, T.; Gergely, P.; Moffatt, C.; Patraskaki, M. S.;
Kokolaki, M. C.; Gkerdi, A.; Skamnaki, V. T.; Leonidas, D. D.;
Somsak, L.; Hayes, J. M.: A multidisciplinary study of 3-(β-d-
glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as
glycogen phosphorylase inhibitors: Computation, synthesis,
crystallography and kinetics reveal new potent inhibitors. Eur.
J. Med. Chem. 147 (2018) 266–278.
7. Anumala, U. R.; Waaler, J.; Nkizinkiko, Y.; Ignatev, A.; Lazarow,
K.; Lindemann, P.; Olsen, P. A.; Murthy,S.; Obaji, E.; Majouga,
A. G.; Leonov, S.; von Kries, J. P.; Lehtioe, L.; Krauss, S.; Nazare,
M.: Discovery of a novel series of tankyrase inhibitors by a
hybridization approach. J. Med. Chem. 60 (2017) 10013–10025.
8. Hernández-Gil, J.; Ferrer, S.; Ballesteros, R.; and Castiñeiras,
A.: N-(5-Amino-1H-1,2,4-triazol-3-yl)pyridine-2-carboxamide.
Acta Crystallogr. E69 (2013) o227–o228, and rerferences
therein.
Unauthenticated
Download Date | 6/24/19 8:31 AM
Tan et al.: C10H17N5O | 763
9. Lim, F. P. L.; Hu, L. M.; Tiekink, E. R. T.; Dolzhenko, A. V.: One-
pot, microwave-assisted synthesis of polymethylene-bridged
bis(1H-1,2,4-triazol-5(3)-amines) and their tautomerism.
Tetrahedron Lett. 59 (2018) 3792–3796.
10. Dolzhenko, A. V.; Tan, G. K.; Koh, L. L.; Dolzhenko, A. V.;
Chui, W. K.: 3-Phenyl-1H-1,2,4-triazol-5-amine-5-phenyl-
1 H-1,2,4-triazol-3-amine (1/1). Acta Crystallogr. E65
(2009) o126.
Unauthenticated
Download Date | 6/24/19 8:31 AM
